|
|
Type of Company:
Type:
|
Company
|
Ownership: |
Privately Held (Funded) |
Company Size: |
20 Employees In BC (20 Total)
20 In BC (20 Total)
|
Year Founded: |
2007 |
Sector: |
Biotech/Life Sciences
Biotech/Life Sciences
|
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
Biolux, light accelerated, orthodontics, implantology, dentistry
|
Profile Views: |
2,376 Company Profile Views |
|
|
|
Biolux Research is a world leader in the development of innovative Light Accelerated Orthodontics™ technology and products for use in orthodontics, implantology, and other dentistry markets. Biolux focuses on product development and clinical research, and its proprietary, patent-pending technologies have been developed to enhance clinical outcomes and dramatically reduce treatment timelines in orthodontics and dentistry in a safe, effective and non-invasive approach. |
|
|
Date |
Type |
Amount |
Investors |
Nov 9, 2007 |
Private Placement |
$0.86 Million CAD |
Elac Venture Corporation and Existing Shareholders and Individual Investors |
Aug 13, 2009 |
Unattributed |
$0.2 Million CAD |
National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) |
Jul 16, 2010 |
Private Placement |
$1 Million CAD |
Convertible debt mechanism offered to existing shareholders and optionholders of the company in
advance of a planned further offering to the broader investment community in the near future. |
Dec 4, 2011 |
Convertible Debt |
$2.4 Million CAD |
Debt issue convertible to common shares, fully subscribed by existing shareholders of the company. |
Date |
Type |
Amount |
Investors |
Nov 9, 2007 |
Private Placement |
$0.86M CAD |
Elac Venture Corporation and Existing Shareholders and Individual Investors |
Aug 13, 2009 |
Unattributed |
$0.2M CAD |
National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) |
Jul 16, 2010 |
Private Placement |
$1M CAD |
Convertible debt mechanism offered to existing shareholders and optionholders of the company in
advance of a planned further offering to the broader investment community in the near future. |
Dec 4, 2011 |
Convertible Debt |
$2.4M CAD |
Debt issue convertible to common shares, fully subscribed by existing shareholders of the company. |
|
|
|
Want More Biolux Research Ltd. News? 1
|
Next »
|
|
|
|
|
|
|
May 6, 2019
|
Vancouver-based Biolux Research Raises $14 Million in Series-A Financing Round led by Venrock; Appoints David Thrower as CEO
|
|
Dec 21, 2016
|
Orthopulse® Announces Next Phase of Sales and Expansion in North America
|
|
Sep 29, 2016
|
Biolux Research and the Schulman Study Group Announce a Partnership Promoting Light Accelerated Orthodontics™
|
|
Sep 27, 2016
|
Biolux Research Announces Irish Distribution Agreement With Promed for Orthopulse®
|
|
Aug 14, 2015
|
Biolux Research Announces FDA Clearance for Orthopulse™
|
|
Dec 11, 2014
|
Biolux Research Announces That Orthopulse™ Receives Regulatory Approval in Canada
|
|
May 28, 2014
|
Biolux Research Announces Orthopulse™ Beta Evaluation Program With the Schulman Study Group
|
|
Mar 7, 2014
|
Biolux Research Announces Appointment of Vice President of Global Sales and Marketing
|
|
Jul 29, 2013
|
Biolux Research Announces Completion of Successful Clinical Study for Light Accelerated Implantology
|
|
May 1, 2013
|
Biolux Research Announces Pilot Study Results and Development of New Intraoral Product
|
|
|
1 - 10 of 25 results
|
|
 |
|
|
|
Share This Company Profile |
|
|
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
Employers
Post Job Listings
Advertise
